Statistics

Total Visits

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study98

Select a period of time:

Number of views in the range

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study48

Views

Views
July 202518
August 20256
September 202510
October 20254
November 20255
December 20254
January 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States19
Brazil16
United Kingdom6
South Africa2
Argentina1
Colombia1
Kenya1
Panama1
Uruguay1
 

Top cities views

Views
Dallas4
Johannesburg2
Ashburn1
Belo Horizonte1
Bogotá1
Bom Jesus de Goiás1
Brasília1
Campina Grande1
Canarana1
Caruaru1